UK biotech IPO's on AIM
This article was originally published in Scrip
Executive Summary
UK biotech firm C4X Discovery (C4XD) has conducted an initial public offering on London's AIM and raised £11m by placing 11 million shares at a £1 each. C4XD's market cap on admission was around £31m.